PROGRAM

Following on from the ground-breaking success of the CAMPs consensus document and JWC masterclass comes the inaugural Cellular, Acellular and Matrix-like Products Wound Care Summit. The two-day program is aimed at physicians and industry, and will provide wound care specialists with the skills and confidence to optimise their use of this advanced therapy and improve patient outcomes.

This CME-accredited event is aimed at KOL practitioners and users of CAMPs, and will feature sessions from some of the world’s leading wound experts, while companies will be on hand to provide demonstrations of the latest technology and techniques in this pioneering method of wound management.


Time Information
07:40 - 08:10
Opening ceremony and breakfast session


08:10 - 09:20
Molecular science of wound care
Mitch Sanders, PhD, Chief Executive Officer, ProDevLabs
Mimi Borrelli, MBBS, PhD, MSc, Medical Science Liaison, AVITA Medical
Andrew Leask, Professor, University of Saskatchewan
Dr. Daniel L. Kapp, M.D, Board-Certified Plastic Surgeon, Private Practice, West Palm Beach, FL
Richard Simman, MD, FACS, FACCWS, Clinical professor of surgery, Plastic Surgery, University of Toledo College of medicine


(CME Accredited session)

This will look at the pathophysiology of skin breakdown and tissue loss, to explain why tissue repair and regeneration can be achieved with advanced therapies, like CAMPs.
Moderated by Richard Simman.

  • Composition and regulatory functions of the extracellular matrix - Mitch Sanders
  • Wnt signaling and its role in injury repairs - Mimi R Borrelli, MBBS, PhD, MSc 
  • Hypoxia-inducible factor in wound healing - Andrew Leask
  • Who is funding basic science in wound repair? How does industry engage these resources? - Daniel L. Kapp
  • Q&A
09:20 - 10:10
Importance of evidence-based treatment algorithms to support wound healing and patient access
Maribel Henao, DPM, MSPT, Senior Director, Medical Affairs, Organogenesis
Antonio S. Montecalvo, Vice President, Health Policy, Organogenesis
Dr. Daniel L. Kapp, M.D, Board-Certified Plastic Surgeon, Private Practice, West Palm Beach, FL


Uniting science and evidence to support the CAMPS Decision Tree and expand patient coverage - Maribel Henao, DPM, MSPT & Antonio S. Montecalvo

Transforming Wound Management: Real-World Insights on advanced CAMPS therapies to support healing and expand patient access - Dr. Daniel L. Kapp, M.D
10:10 - 10:40
Morning break & exhibition viewing


10:40 - 11:05
Introduction to CAMPs
Jeffrey A. Niezgoda, MD, MAPWC, FACHM, CHWS, President WebCME, CMO Kent Imaging / RxOS Medical / Auxillium Health


(CME Accredited session)
This will explain the rationale for the term CAMPs, introduced in the 2022 JWC consensus document, which is designed to capture the diversity of available biomaterials and bioengineering introduced in the past 2 decades.
Moderated by Tracy Cowan
  • CAMPs: ingredients and categorization
  • Q&A
11:05 - 11:45
Update on the clinical and economic research base
Stephanie Wu, DPM, MSc, FACFAS, Dean, Professor of Surgery, Professor, Stem Cell and Regenerative Medicine, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science
Dr. William H. Tettelbach, Chief Medical Officer, RestorixHealth


(CME Accredited session)
This session looks at the latest research evidence on the clinical and cost-effectiveness of CAMPs.
Moderated by Tracy Cowan.
  • Clinical evidence for using CAMPs on non-healing diabetic foot ulcers - Stephanie Wu
  • Q&A
  • The economic evidence base: are CAMPs truly cost-effective? - Dr. William H. Tettelbach
  • Q&A
11:45 - 12:15
Leveraging CAMPs: Wound Management One Patient at a Time
Roselle Crombie, MD-MPH, FACS, FABA, Yale New Haven Health


12:15 - 13:45
Lunch & exhibition viewing


13:45 - 15:05
Accepted best practice for CAMPs: are we falling short?
John C. Lantis, Chief of Surgery, Mount Sinai West Hospital
Dr. William H. Tettelbach, Chief Medical Officer, RestorixHealth


(CME Accredited session)
The aim is to clarify the steps required to prepare the wound for application of CAMPs, to ensure optimal clinical outcomes.
Moderated by Tracy Cowan
  • Assessment and selection - John Lantis
  • Wound bed preparation - Dr. William H. Tettelbach
  • Initiation - Dr. William H. Tettelbach
  • CAMP application frequency - Dr. William H. Tettelbach
  • Q&A
15:05 - 15:30
Keeping Wounds Closed: The Use of Viable Placental Allografts for Diabetic Foot Ulcers
Dr. Thomas Groner DPM. AACFAS., Podiatry specialist, Noms Ankle And Foot Care Centers


This session will review clinical evidence, case studies and discuss the associated recurrence rate utilizing Grafix Membrane on diabetic foot ulcers.

Cellular, acellular and matrix‑like products (CAMPs) and/or tissue-based products (CTPs) have advanced greatly in the past several decades and improve the ability to close wounds more efficiently.  CAMPS are developed as wound covers for a wide variety of acute and chronic wounds in head-to-toe locations. Dr Groner will share key benefits that patients have observed when receiving treatment with CAMPS when he discusses his real-world clinical cases in podiatric surgery.
15:30 - 16:00
Afternoon break & exhibition viewing


16:00 - 18:00
Optimizing CAMP use: identifying new applications
Adam L. Isaac, DPM, FACFAS, Podiatrist , US Foot and Ankle Specialists
Dr. Paul Glat, Professor of Surgery, Drexel University College of Medicine
Rebecca Aburn, Nurse Practitioner – vascular, Te Whatu Ora
Suzanne Moloney, Founder/CEO HidraMed Solutions, HidraMed Solutions, University of Ireland
Hadar Lev-Tov, MD, Associate professor, University of Miami
Richard Simman, MD, FACS, FACCWS, Clinical professor of surgery, Plastic Surgery, University of Toledo College of medicine
Abigail E. Chaffin, MD, FACS, CWSP, MAPWCA, Professor and Chief, Tulane University Division of Plastic Surgery, Tulane University


(CME Accredited session)
There is emerging evidence that patients with indications not previously considered for CAMPs would benefit greatly from their use — this session explores these new applications further.
Moderated by John Lantis.
  • Wagner stage 3 and over DFUs - Dr. Adam Isaac
  • Burns - Dr. Paul Glat
  • Pyoderma gangrenosum - Rebecca Aburn
  • Hidradenitis suppurativa - Suzanne Moloney & Hadar Lev-Tov
  • Cutaneous malignancy excisions - Richard Simman
  • Complicated pilonidal cyst surgical wounds - Dr Abigail Chaffin 
  • Exposed tendon and bone - Richard Simman
  • Q&A
19:00 - 21:30
Evening mixer


Time Information
07:30 - 08:40
Overcoming the threat to CAMP coverage
Thomas E. Serena, MD, FACS, FACHM, MAPWCA, CEO and Medical Director, SerenaGroup Inc and SerenaGroup Research Foundation
Jennie Feight, MS, CPC, CPMA, CPC-I, Director, Health Policy, MIMEDX Group, Inc.


(CME Accredited session)
Possible restrictions to access of CAMPs, with new limits on reimbursement and number of applications covered, are causing alarm among physicians. Why has this happened?
Moderated by Tracy Cowan

  • The threat to date: how did we get here? - Thomas E. Serena
  • Clinical trials and registries - Thomas E. Serena
  • Minimal data required for reimbursement - Thomas E. Serena
  • The case for enforced reporting of average sales prices - Jennie Feight
  • Q&A
08:40 - 09:10
Working together to protect coverage: success requires solidarity
Dr. William H. Tettelbach, Chief Medical Officer, RestorixHealth
Thomas E. Serena, MD, FACS, FACHM, MAPWCA, CEO and Medical Director, SerenaGroup Inc and SerenaGroup Research Foundation
Eric J. Lullove DPM CWSP DABLES APWH(c) FFPM RCPS (Glasg), Chief Medical Officer, West Boca Center for Wound Healing


(CME Accredited session)
As part of a campaign to head off these restraints, a long-term strategy centring around the generation of top level clinical and economic research data is needed. Only then can the value of CAMPs be fully demonstrated.
  • Panel debate to formulate a strategy with audience engagement
  • Q&A
09:10 - 09:45
Avoiding reimbursement denials: clinical documentation and coding to pass TPE audits
Kathleen D. Schaum, President, Kathleen D. Schaum & Associates, Inc.


(CME Accredited session)
Insights into best practice for avoiding reimbursement denials
09:45 - 10:10
How to appeal successfully when reimbursement is declined
Erin Ferber, Esq., Partner, Nicholson & Eastin, LLP


(CME Accredited session)
What to do when a request for reimbursement of CAMPs is declined. 
10:10 - 11:05
Health disparities and lessons from the real world
Joseph Rolley, Principal, JTR Business Consulting LLC
Caroline E. Fife, MD, CMO, Intellicure, LLC, Intellicure, LLC
Stephanie Wu, DPM, MSc, FACFAS, Dean, Professor of Surgery, Professor, Stem Cell and Regenerative Medicine, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science


(CME Accredited session)
Multifaceted strategies for increasing access to Medicaid.
Moderated by Stephanie Wu
  • Improving access - Joseph Rolley
  • Optimising outcomes data - Caroline Fife
  • State legislature perspective - High-profile government speaker to be announced!
  • Q&A
11:05 - 11:35
A common sense approach to proper documentation and billing for compliance and reimbursement
Dr. Lonnie Lassiter, II M.D., M.B.A, FACCWS, ,


11:35 - 14:10
Lunch, poster and exhibition viewing


The following will take place in the exhibit hall between 11:35am – 2:10pm make sure to visit the booths!

  • 11:35am - 12:35pm: Explore the creativity and research showcased in our poster display.
  • 11:35am - 2:10pm: Immerse yourself in our exhibition area.

  • 12pm - 1pm: Fuel up during our lunch break.

  • 1:10pm - 2:10pm: Don't miss our 'Meet the innovators' session: This is a product presentation, plus deep dive into mode of action and top-line clinical and economic data. Watch industry showcase the latest developments in CAMPs technology, and then take part in the Q&A session with them.
14:10 - 14:35
Effective Decellularization: The Evolution of Wound Care
Dr. Andrew Rader, Podiatry Specialist, Indiana Foot & Ankle – Founder/Owner


  • Examine the scientific impact and value of decellularization of ECM
  • Investigate the benefits of ECM on surgical outcomes (reduction of hospital readmissions and scarring) and explore patient populations that would most benefit 
  • Explore techniques and clinical outcomes of ECM use in surgical wounds and soft tissue
  • Apply the science of ECM to clinical applications 
14:35 - 15:35
Improving market access
Susan Z Paquette, VP & GM, Wound, SmartTRAK
Mitch Sanders, PhD, Chief Executive Officer, ProDevLabs
Joseph Rolley, Principal, JTR Business Consulting LLC


(CME Accredited session)
Insights into the processes involved, from product development in the lab to gaining market access and reimbursement.
Moderated by Daniel L. Kapp.

  • Market dynamics and market drivers - Susan Paquette
  • From the laboratory to CMS approval - Mitch Sanders, PhD
  • Overcoming the challenge of Medicare Advantage - Joe Rolley
  • Infiltrating the commercial payer space - Joe Rolley
  • Q&A
15:35 - 16:20
Afternoon break & exhibition viewing


16:20 - 16:50
16:50 - 17:30